QURE uniQure NV
- Stocks
- Healthcare
- NASDAQ: QURE
Price (delayed)
$14.6
Market cap
$801.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.92
Enterprise value
$1.07B
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
Highlights
The gross margin has soared by 53% since the previous quarter
The company's EPS rose by 34% YoY and by 11% QoQ
The quick ratio is up by 41% year-on-year but it is down by 17% since the previous quarter
The equity has shrunk by 112% QoQ and by 104% YoY
The company's revenue fell by 48% YoY and by 29% QoQ
Key stats
What are the main financial stats of QURE
Market
Valuations
Earnings
Shares outstanding
54.87M
Market cap
$801.06M
Enterprise value
$1.07B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
55.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
74.58
Revenue
$14.34M
Gross profit
$11.84M
Operating income
-$169.25M
Net income
-$199M
EBIT
-$135.06M
EBITDA
-$119.56M
Free cash flow
-$182.56M
Per share
Balance sheet
Liquidity
EPS
-$3.92
EPS diluted
-$3.92
Free cash flow per share
-$3.33
Book value per share
-$0.07
Revenue per share
$0.26
TBVPS
$8.83
Total assets
$584.89M
Total liabilities
$588.89M
Debt
$521.96M
Equity
-$4M
Working capital
$367.64M
Debt to equity
-130.39
Current ratio
9.98
Quick ratio
9.35
Net debt/EBITDA
-2.24
Margins
Efficiency
Dividend
EBITDA margin
-833.9%
Gross margin
82.6%
Net margin
-1,388%
Operating margin
-1,180.5%
Return on assets
-33.3%
Return on equity
-1,010.7%
Return on invested capital
-18.2%
Return on capital employed
-24.8%
Return on sales
-942.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QURE stock price
How has the uniQure stock price performed over time
Intraday
2.1%
1 week
8.23%
1 month
1.39%
1 year
107.39%
YTD
-17.33%
QTD
4.73%
Financial performance
How have uniQure's revenue and profit performed over time
Revenue
$14.34M
Gross profit
$11.84M
Operating income
-$169.25M
Net income
-$199M
Gross margin
82.6%
Net margin
-1,388%
The gross margin has soared by 53% since the previous quarter
The company's revenue fell by 48% YoY and by 29% QoQ
The operating margin has contracted by 41% from the previous quarter and by 35% YoY
The net margin fell by 35% YoY and by 29% QoQ
Price vs fundamentals
How does QURE's price correlate with its fundamentals
Growth
What is uniQure's growth rate over time
Valuation
What is uniQure stock price valuation
P/E
N/A
P/B
N/A
P/S
55.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
74.58
The company's EPS rose by 34% YoY and by 11% QoQ
The equity has shrunk by 112% QoQ and by 104% YoY
The P/S is 89% higher than the 5-year quarterly average of 29.0 and 80% higher than the last 4 quarters average of 30.3
The company's revenue fell by 48% YoY and by 29% QoQ
Efficiency
How efficient is uniQure business performance
The return on equity has dropped by 109% since the previous quarter
The company's return on sales fell by 25% QoQ and by 20% YoY
The return on invested capital has increased by 22% year-on-year and by 9% since the previous quarter
The ROA has grown by 6% YoY and by 2.9% from the previous quarter
Dividends
What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QURE.
Financial health
How did uniQure financials performed over time
The quick ratio is up by 41% year-on-year but it is down by 17% since the previous quarter
The current ratio has grown by 36% YoY but it has contracted by 17% from the previous quarter
The equity has shrunk by 112% QoQ and by 104% YoY
The debt fell by 2.3% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.